FDA warned Zhejiang Xichen Medical Technology for selling three face masks in the U.S. without FDA clearance and for misleading FDA registration claims.
What happened
FDA reviewed the company's website on March 23, 2021, and found the FFP2 NR 5-Layer KN95 Face Mask, Medical Face Mask, and Sterile Surgical Mask offered for sale in the United States with claims to prevent COVID-19, infection, and bacteria. FDA said the masks lacked marketing approval, clearance, or authorization and that the site displayed an "FDA REGISTRATION CERTIFICATE" bearing the FDA logo, which falsely suggests FDA approval.
What FDA found
The website claims the masks prevent COVID-19, infection, and bacteria, which makes them medical devices under the law.
Section 201(h), 21 U.S.C. § 321(h)The masks are offered for sale in the U.S. with no approved premarket approval application or investigational device exemption, which makes them adulterated.
Section 501(f)(1)(B), 21 U.S.C. § 351(f)(1)(B); sections 515(a) and 520(g)The company did not notify FDA of its intent to market the devices, which makes them misbranded.
Section 502(o), 21 U.S.C. § 352(o); section 510(k)The site displays a certificate using the FDA logo and an FDA database screenshot that imply FDA approval or endorsement of the company and its masks.
Section 502(a), 21 U.S.C. § 352(a); 21 CFR 807.39The Sterile Surgical Mask page states the product has a "Certificate CE, FDA," which further misleads buyers.
Section 502(a), 21 U.S.C. § 352(a)
What FDA wants
FDA asked the company to immediately stop selling any adulterated or misbranded products intended to mitigate, prevent, treat, diagnose, or cure COVID-19, and to write back within 15 business days describing the corrective steps taken and how it will prevent repeat violations.
Who should pay attention
- U.S. importers and distributors of foreign-made face masks
- buyers who rely on supplier-issued "FDA registration certificates"
- brands that private-label or resell PPE from overseas manufacturers
This is a summary. Read the original letter on fda.gov.